Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Castinetti

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2026
Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical CarcinomasRossella Libé, Matthieu Faron, Anne-Sophie Foucan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2022
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 CasesIulia Potorac, Jean-François Bonneville, Adrian F Daly, et al.
Endocrine-Related Cancer|June 27, 2017
The penetrance of MEN2 pheochromocytoma is not only determined by <i>RET</i> mutationsFrederic Castinetti, Ana Luiza Maia, Mariola Peczkowska, et al.
Endocrine Connections|May 7, 2020
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studyLouise Vølund Larsen, Delphine Mirebeau-Prunier, Tsuneo Imai, et al.
Nature Reviews. Endocrinology|June 24, 2025
Pituitary incidentaloma: a Pituitary Society international consensus guideline statementMaria Fleseriu, Mark Gurnell, Ann McCormack, et al.
American Journal of Human Genetics|July 16, 2021
High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiencyPeter Gergics, Cathy Smith, Hironori Bando, et al.
Endocrine-Related Cancer|September 22, 2016
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegalyIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
Annales D'Endocrinologie|February 5, 2026
Prevalence, risk factors and management of bone complications in Cushing`s syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN)Aleksandra Zdrojowy-Wełna, Claudia Amaral, Marta Araujo-Castro, et al.
JAMA Network Open|August 10, 2019
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing AdrenalectomyHartmut P H Neumann, Uliana Tsoy, Irina Bancos, et al.
The Lancet. Diabetes & Endocrinology|October 23, 2021
Consensus on diagnosis and management of Cushing's disease: a guideline updateMaria Fleseriu, Richard Auchus, Irina Bancos, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2026
Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical CarcinomasRossella Libé, Matthieu Faron, Anne-Sophie Foucan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2022
Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 CasesIulia Potorac, Jean-François Bonneville, Adrian F Daly, et al.
Endocrine-Related Cancer|June 27, 2017
The penetrance of MEN2 pheochromocytoma is not only determined by <i>RET</i> mutationsFrederic Castinetti, Ana Luiza Maia, Mariola Peczkowska, et al.
Endocrine Connections|May 7, 2020
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studyLouise Vølund Larsen, Delphine Mirebeau-Prunier, Tsuneo Imai, et al.
Nature Reviews. Endocrinology|June 24, 2025
Pituitary incidentaloma: a Pituitary Society international consensus guideline statementMaria Fleseriu, Mark Gurnell, Ann McCormack, et al.
American Journal of Human Genetics|July 16, 2021
High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiencyPeter Gergics, Cathy Smith, Hironori Bando, et al.
Endocrine-Related Cancer|September 22, 2016
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegalyIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
Annales D'Endocrinologie|February 5, 2026
Prevalence, risk factors and management of bone complications in Cushing`s syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN)Aleksandra Zdrojowy-Wełna, Claudia Amaral, Marta Araujo-Castro, et al.
JAMA Network Open|August 10, 2019
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing AdrenalectomyHartmut P H Neumann, Uliana Tsoy, Irina Bancos, et al.
The Lancet. Diabetes & Endocrinology|October 23, 2021
Consensus on diagnosis and management of Cushing's disease: a guideline updateMaria Fleseriu, Richard Auchus, Irina Bancos, et al.
Pageof 14